Bernd O. Wetzel
Corporate Officer/Principal bei Atugen AG
Ursprung des Netzwerks ersten Grades von Bernd O. Wetzel
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Atugen AG
Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Bernd O. Wetzel
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Director/Board Member | |
Shell Capital, Inc.
Shell Capital, Inc. Oil & Gas ProductionEnergy Minerals Part of Shell Plc, Shell Capital, Inc. is a company based in Houston, TX. | Oil & Gas Production | Corporate Officer/Principal | |
ZENYTH THERAPEUTICS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
EACOM Timber Corp.
EACOM Timber Corp. Forest ProductsNon-Energy Minerals EACOM Timber Corp. engages in the manufacture and distribution of lumber and wood-based products, and the management of forest resources. It offers stud grade lumber, dimension lumber, machine-stress rated lumber, specialty lumber and engineered woods. The company was founded by Hassan Salari on April 2, 1980 and is headquartered in Montreal, Canada. | Forest Products | Chairman | |
Millenium Biologix Corp.
Millenium Biologix Corp. BiotechnologyHealth Technology Millenium Biologix Corp. is focused on the development and commercialization of next generation, skeletal tissue regeneration products and implantable medical devices, initially targeted for orthopedic uses. These products, used alone or in combination configurations, promote the repair and natural healing of human bone and other skeletal tissues such as cartilage. Millenium's strength in developing leading treatments for regenerative medicine is based on its successful integration of three core competencies in advanced biomaterials, biologics and engineering. Its core business activities are focused on tissue engineering products, and on orthobiologicals. It was founded on April 1, 1998 and is headquartered in Kingston, ON. | Biotechnology | Director/Board Member | |
Metriopharm AG
Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
The Institute of Cancer Research: Royal Cancer Hospital
The Institute of Cancer Research: Royal Cancer Hospital Miscellaneous Commercial ServicesCommercial Services The Institute of Cancer Research: Royal Cancer Hospital operates as a cancer research institution. The company was founded in 1909 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
AVITA MEDICAL, INC. | Medical Specialties | Director/Board Member | |
Biocontrol Ltd. (United Kingdom)
Biocontrol Ltd. (United Kingdom) BiotechnologyHealth Technology Biocontrol Ltd. develops treatment to cure antibiotic resistant infections. The company was founded by David Harper on October 20, 1997 and is headquartered in Newbury, the United Kingdom. | Biotechnology | Director/Board Member | |
ARMATA PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer | |
Arecor Ltd.
Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Summatix Pty Ltd.
Summatix Pty Ltd. Internet Software/ServicesTechnology Services Summatix Pty Ltd. operates as a medical data monetization platform. The firm provides connectivity to its HIPAA compliant platform, software, APIs, and data management. The company is headquartered in Melbourne, Australia. | Internet Software/Services | Director/Board Member | |
Virgin Health Bank Ltd.
Virgin Health Bank Ltd. Medical/Nursing ServicesHealth Services Virgin Health Bank Ltd. provides umbilical cord blood stem cell banking services. It offers family banking and community banking. The company was founded in 2009 and is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Investment Managers | Director/Board Member | |
Max-Planck-Institute for Molecular Genetics | College/University | Chief Tech/Sci/R&D Officer | |
Howard Hughes Medical Institute, Inc.
Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Investment Trusts/Mutual Funds | Chief Tech/Sci/R&D Officer | |
Freie Universität Berlin | College/University | Doctorate Degree | |
PYC THERAPEUTICS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
University of Hamburg | College/University | Graduate Degree | |
Westminster School (United Kingdom) | College/University | Undergraduate Degree | |
CUBE Labs Srl
CUBE Labs Srl Investment ManagersFinance Cube Labs Srl (Cube Labs) is a venture capital subsidiary of Cube Labs SpA founded in 2013 by Filippo Surace and Renato del Grosso. The firm is headquartered in Rome, Italy. | Investment Managers | Consultant / Advisor | |
Smart Matrix Ltd.
Smart Matrix Ltd. Financial ConglomeratesFinance Smart Matrix Ltd. engages in the research and development of medical solutions. It focuses on commercializing its propriety platform technology Smart Matrix, a medical device that acts as a scaffold to assist wound healing. The company was founded in 2011 and is headquartered in London, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
ADHERIUM LIMITED | Medical Specialties | Director/Board Member | |
Rosetta Capital Ltd.
Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital Ltd (Rosetta Capital) is a venture capital firm is founded in 2001 by Jeremy Curnock Cook, Michael Forer and Jonathan Hepple. The firm is headquartered in London. | Investment Managers | Chairman | |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Biotechnology | Director/Board Member | |
Trinity College Dublin | College/University | Graduate Degree |
Statistik
International
Vereinigtes Königreich | 12 |
Vereinigte Staaten | 10 |
Australien | 6 |
Kanada | 6 |
Deutschland | 4 |
Sektoral
Health Technology | 17 |
Commercial Services | 6 |
Consumer Services | 6 |
Finance | 5 |
Miscellaneous | 4 |
Operativ
Director/Board Member | 52 |
Chairman | 13 |
Chief Executive Officer | 11 |
Independent Dir/Board Member | 10 |
Corporate Officer/Principal | 7 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Jeremy Curnock-Cook | 60 |
Thomas Christély | 8 |
Klaus Giese | 7 |
- Börse
- Insiders
- Bernd O. Wetzel
- Unternehmensverbindungen